Global Trade leader ecrobot

Mar 11 2026

Description Aficamten is a next‑generation, oral, selective allosteric inhibitor of cardiac myosin. It binds to the myosin catalytic domain, stabilizes the weak actin‑binding state, and reduces ATPas…

HS-CODE : -

Category :

Hangzhou JINLAN Pharm-Dr...

China [CN]

Scince 0

Free Member

Mavacamten

Mar 11 2026

Description Mavacamten is a first-in-class, oral, selective allosteric inhibitor of cardiac myosin.It modulates cardiac contractility by decreasing actin-myosin cross-bridge formation,reducing hyperc…

HS-CODE : -

Category :

Hangzhou JINLAN Pharm-Dr...

China [CN]

Scince 0

Free Member

Baloxavir Marboxil

Mar 11 2026

Description Baloxavir Marboxil is a first-in-class, oral anti-influenza virus drugthat inhibits the influenza virus cap-dependent endonuclease,blocking viral mRNA transcription and replication. Appr…

HS-CODE : -

Category :

Hangzhou JINLAN Pharm-Dr...

China [CN]

Scince 0

Free Member

Lenacapavir Sodium

Mar 11 2026

Description Lenacapavir is a first-in-class, long-acting HIV-1 capsid inhibitor that binds to the viral capsid protein and blocks multiple steps in the HIV lifecycle, including capsid assembly, disas…

HS-CODE : -

Category :

Hangzhou JINLAN Pharm-Dr...

China [CN]

Scince 0

Free Member

Tenofovir Alafenamide Fumarate

Mar 11 2026

DescriptionTenofovir alafenamide (TAF) is a prodrug of tenofovir with improved liver and plasma stability compared to TDF.It delivers higher active drug intracellularly with lower systemic tenofovir e…

HS-CODE : -

Category :

Hangzhou JINLAN Pharm-Dr...

China [CN]

Scince 0

Free Member

Velpatasvir

Mar 11 2026

DescriptionVelpatasvir is a highly potent, pan‑genotypic HCV NS5A inhibitor that blocks viral assembly and replication. It is almost exclusively used in fixed‑dose combination with sofosbuvir to achie…

HS-CODE : -

Category :

Hangzhou JINLAN Pharm-Dr...

China [CN]

Scince 0

Free Member

Sofosbuvir

Mar 11 2026

DescriptionSofosbuvir is a nucleotide analog inhibitor of the hepatitis C virus (HCV) NS5B RNA‑dependent RNA polymerase. It acts as a chain terminator, blocking viral replication. It is a cornerstone …

HS-CODE : -

Category :

Hangzhou JINLAN Pharm-Dr...

China [CN]

Scince 0

Free Member

Darolutamide

Mar 11 2026

Description Darolutamide is a second‑generation, oral androgen receptor (AR) antagonist with high affinity for the AR. It inhibits AR nuclear translocation, DNA binding, and AR‑mediated transcription…

HS-CODE : -

Category :

Hangzhou JINLAN Pharm-Dr...

China [CN]

Scince 0

Free Member

Apalutamide

Mar 11 2026

DescriptionApalutamide is an oral, selective, competitive androgen receptor (AR) inhibitor that blocks androgen binding, nuclear translocation, and AR-mediated transcription, thereby inhibiting prosta…

HS-CODE : -

Category :

Hangzhou JINLAN Pharm-Dr...

China [CN]

Scince 0

Free Member

Lumateperone Tosylate

Mar 11 2026

Description Lumateperone Tosylate is an oral atypical antipsychotic with a unique mechanism of action, targeting serotonin, dopamine, and glutamate pathways simultaneously. It shows balanced modulati…

HS-CODE : -

Category :

Hangzhou JINLAN Pharm-Dr...

China [CN]

Scince 0

Free Member

Brensocatib

Mar 11 2026

Description Brensocatib is an oral, competitive, reversible inhibitor of DPP1. It blocks the activation of neutrophil serine proteases (NSPs: NE, PR3, CatG) during neutrophil maturation, reducing air…

HS-CODE : -

Category :

Hangzhou JINLAN Pharm-Dr...

China [CN]

Scince 0

Free Member

Abemaciclib

Mar 11 2026

DescriptionAbemaciclib is an oral, highly selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6).It induces cell-cycle arrest in G1 phase and inhibits proliferation in HR+/HER2- breast cance…

HS-CODE : -

Category :

Hangzhou JINLAN Pharm-Dr...

China [CN]

Scince 0

Free Member

Ribociclib

Mar 11 2026

Approved Indications HR-positive, HER2-negative advanced or metastatic breast cancer in combination with: Aromatase inhibitors Fulvestrant Key Features Potent and selective CDK4/6 inhibition …

HS-CODE : -

Category :

Hangzhou JINLAN Pharm-Dr...

China [CN]

Scince 0

Free Member

Ribociclib

Mar 11 2026

Approved Indications HR-positive, HER2-negative advanced or metastatic breast cancer in combination with: Aromatase inhibitors Fulvestrant Key Features Potent and selective CDK4/6 inhibition …

HS-CODE : -

Category :

Hangzhou JINLAN Pharm-Dr...

China [CN]

Scince 0

Free Member

Pirtobrutinib

Mar 11 2026

Pirtobrutinib - English API Data SheetName: Pirtobrutinib (LOXO‑305, LY3527727)CAS: 2101700‑15‑4Formula: C₂₂H₂₁F₄N₅O₃Molecular Weight: 479.44Class: Non‑covalent Bruton’s Tyrosine Kinase (BTK) inhibito…

HS-CODE : -

Category :

Hangzhou JINLAN Pharm-Dr...

China [CN]

Scince 0

Free Member